Studies indicate that ER-negative breast cancer cells seems to have extensive deregulations in their estrogen receptor pathway since restored ER expression in ER-negative breast cancer cells did not restore the ability of estrogen to stimulate proliferation [27]. The gene discussed is ESR1; the disease is breast cancer.